Skip to main content
OPTIBIOTIX HEALTH PLC logo

OPTIBIOTIX HEALTH PLC — Investor Relations & Filings

Ticker · OPTI ISIN · GB00BP0RTP38 LEI · 213800UKYQFT941QHS14 IL Manufacturing
Open in API
Filings indexed 477 across all filing types
Latest filing 2026-06-02 Regulatory Filings
Country GB United Kingdom
Listing IL OPTI

About OPTIBIOTIX HEALTH PLC

https://www.optibiotix.com/

OptiBiotix Health PLC is a life sciences company specializing in the research and development of technologies that modulate the human microbiome. The company identifies and develops microbial strains, compounds, and formulations for use as food ingredients, dietary supplements, and active compounds. Its primary focus is on the prevention and management of chronic lifestyle diseases, including obesity, cardiovascular health issues such as high cholesterol, and diabetes. OptiBiotix's approach is founded on strong scientific evidence, with its product pipeline supported by clinical human studies. The company provides these clinically proven ingredients and white-label solutions to partners in the food, health, and wellness sectors.

Recent filings

Filing Released Lang Actions
Investor presentation and SweetBiotix® Sampling
Regulatory Filings Classification · 58% confidence The document is a non‐regulatory RNS Reach announcement describing the scheduling of an investor presentation event and product sampling (“further to the announcement on 14 May 2026… booking a venue…”). It does not include the presentation materials themselves, nor any financial statements, voting results, or regulatory filings. It is essentially a general announcement/fallback item distributed via RNS, so it best fits under the “Regulatory Filings” fallback category (RNS).
2026-06-02 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is an RNS announcement detailing the purchase of ordinary shares by a director (David Blain), including share quantities, prices, and resultant holdings. This is a classic insider transaction notification under MAR. It matches the definition of a Director's Dealing report (insider share transaction by a director).
2026-05-29 English
Final Results & Notice of AGM
Earnings Release Classification · 90% confidence The document is a UK RNS announcement titled “Final results and Notice of Annual General Meeting” for the 12 months ended December 31, 2025. It provides audited full-year financial highlights (revenues, profit margins, cash balances, post-period events), and is the preliminary results announcement rather than a full Annual Report. It includes a notice of the AGM but does not include complete financial statements. This matches our definition for an Earnings Release (ER) – an initial announcement of periodical financial results with key highlights. FY 2025
2026-05-28 English
SweetBiotix® Sampling
Regulatory Filings Classification · 80% confidence The document is a non-regulatory “Reach” announcement via RNS describing a product sampling event (SweetBiotix® Sampling) and invitation to shareholders. It contains no financial results, voting information, filings of reports, or corporate actions. It is essentially a general press release distributed through RNS Reach, fitting the fallback category for miscellaneous regulatory announcements.
2026-05-14 English
Partial Disposal of Shares in SkinBioTherapeutics
Regulatory Filings Classification · 95% confidence The document is an announcement by OptiBiotix Health plc regarding the partial disposal of its shareholding in another company, SkinBioTherapeutics. It provides details on the number of shares sold, proceeds generated, and the remaining shareholding percentage. The document is dated 01 May 2026 and is identified as an RNS (Regulatory News Service) announcement. There are no financial statements, detailed financial performance data, or management analysis present. The content focuses on a transaction involving shareholding disposal, which is a change in major shareholding but does not indicate crossing a significant ownership threshold. It is not a full report, earnings release, or management discussion. Given the nature of the announcement and the lack of detailed financial data, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-05-01 English
Trading Update
Earnings Release Classification · 90% confidence The document is a trading update published via RNS providing unaudited key financial highlights for the year ended 31 December 2025. It is not a full statutory report (Annual Report or Interim Report) but an initial announcement of periodical financial results. This fits the definition of an Earnings Release (ER). FY 2025
2026-04-01 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.